Transcriptomic Signature Predicts the Distant Relapse in Patients With ER+ Breast Cancer Treated With Tamoxifen for Five Years
Molecular Medicine Reports - Greece
doi 10.3892/mmr.2017.8234
Full Text
Open PDFAbstract
Available in full text
Date
December 8, 2017
Authors
Publisher
Spandidos Publications